metricas
Archivos de la Sociedad Española de Oftalmología (English Edition) Bilateral and multifocal central serous chorioretinopathy after injecting triamc...
Journal Information
Vol. 95. Issue 3.
Pages 105-156 (March 2020)
Cite
Cite
Share
Download PDF
More article options
Visits
526
Vol. 95. Issue 3.
Pages 105-156 (March 2020)
Short communication

Bilateral and multifocal central serous chorioretinopathy after injecting triamcinolone into a chalazion

Coriorretinopatía serosa central bilateral y multifocal después de inyectar triamcinolona en un chalazión
Visits
526
V.M. Asensio-Sánchez
Corresponding author
, L. Pareja-Aricó, J. Valentín-Bravo
Hospital Clínico Universitario de Valladolid, Valladolid, Spain
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Abstract

We present a case of bilateral and multifocal central serous chorioretinopathy (CSC) that developed 1 month after an intra-chalazion triamcinolone acetonide injection. CSC spontaneously resolved during observation at 3 months after diagnosis. We believe that CSC can occur as a complication of administration of depot corticosteroids even at a low dose.

Keywords:
Central serous chorioretinopathy
Corticosteroid
Bilateral
Multifocal
Triamcinolone
Chalazion
Resumen

Se describe un caso de coriorretinopatía serosa central (CSC) bilateral y multifocal que se desarrolló 1 mes después de una inyección de acetónido de triamcinolona en un chalazión. La CSC se resolvió espontáneamente durante la observación a los 3 meses después del diagnóstico. Consideramos que la CSC puede ocurrir como una complicación de la administración de corticosteroides de depósito incluso a una dosis baja.

Palabras clave:
Coriorretinopatía serosa central
Corticoide
Bilateral
Multifocal
Triamcinolona
Chalazión

Article

These are the options to access the full texts of the publication Archivos de la Sociedad Española de Oftalmología (English Edition)
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
References
[1]
M. Gemenetzi, G. De Salvo, A.J. Lotery.
Central serous chorioretinopathy: an update on pathogenesis and treatment.
Eye (Lond), 24 (2010), pp. 1743-1756
[2]
R. Haimovici, S. Koh, D.R. Gagnon, T. Lehrfeld, S. Wellik.
Risk factors for central serous chorioretinopathy: a case-control study.
Ophthalmology, 111 (2004), pp. 244-249
[3]
M.K. Tittl, R.F. Spaide, D. Wong, E. Pilotto, L.A. Yannuzzi, Y.L. Fisher, et al.
Systemic findings associated with central serous chorioretinopathy.
Am J Ophthalmol, 128 (1999), pp. 63-68
[4]
B. Nicholson, J. Noble, F. Forooghian, C. Meyerle.
Central serous chorioretinopathy: update on pathophysiology and treatment.
Surv Ophthalmol, 58 (2013), pp. 103-126
[5]
B. Liu, T. Deng, J. Zhang.
Risk factors for central serous chorioretinopathy: A systematic review and meta-analysis.
[6]
T. Sharma, N. Shah, M. Rao, L. Gopal, M.P. Shanmugam, M. Gopalakrishnan, et al.
Visual outcome after discontinuation of corticosteroids in atypical severe central serous chorioretinopathy.
Ophthalmology, 11 (2004), pp. 1708-1714
[7]
M. Zhao, I. Célérier, E. Bousquet, J.C. Jeanny, L. Jonet, M. Savoldelli, et al.
Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy.
J Clin Invest, 122 (2012), pp. 2672-2679
[8]
L.Y. Chan, R.S. Adam, D.N. Adam.
Localized topical steroid use and central serous retinopathy.
J Dermatolog Treat, 27 (2016), pp. 425-426
[9]
T. Araki, H. Ishikawa, C. Iwahashi, M. Niki, Y. Mitamura, M. Sugimoto, et al.
Central serous chorioretinopathy with and without steroids: A multicenter survey.
PLoS One, 14 (2019), pp. e0213110
[10]
L. Rosignoli, S.M. Potter, A. Gonzalez, S. Amin, S.G. Khurshid.
Development of central serous chorioretinopathy following chalazion removal with intralesional triamcinolone injection: A Case Report.
Case Rep Ophthalmol, 9 (2018), pp. 416-420
asdasdasd
Article options
Tools